Tekla Healthcare Valuation
| XHQHX Fund | USD 19.24 0.04 0.21% |
Based on Macroaxis valuation methodology, the fund is fairly valued. Tekla Healthcare Inv has a current Real Value of $19.35 per share. The regular price of the fund is $19.24. Our model measures the value of Tekla Healthcare Inv from inspecting the fund technical indicators and probability of bankruptcy. In general, investors recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will draw towards each other.
Tekla Healthcare Total Value Analysis
Tekla Healthcare Investors is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Tekla Healthcare fundamentals before making investing decisions based on enterprise value of the companyTekla Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Tekla suggests not a very effective usage of assets in December.About Tekla Healthcare Valuation
Our relative valuation model uses a comparative analysis of Tekla Healthcare. We calculate exposure to Tekla Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tekla Healthcare's related companies.Other Information on Investing in Tekla Mutual Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |